Escilab is a Polish, privately owned pharmaceutical company that specializes in research, development and market introduction as well as in commercialization (IP out-licensing) of products for nutritional and metabolic disorders. In the company pipeline there are also projects from the area of vascular diseases, including rare congenital syndromes.
